BOB体育

The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to Placebo in the鈥�

Investigator

Angela Pham

Ages

16 Years - 80 Years

Sexes

All

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). The purpose of this study is to assess how safe and effective lutikizumab is in adult鈥�

Investigator

Angela Pham

Ages

18 Years - N/A

Sexes

All